Bicycle Therapeutics Ltd (BCYC) — Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Bicycle Therapeutics Ltd (BCYC) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($34.10 Million) in capital expenditures ($277.00K). See how leveraged is Bicycle Therapeutics Ltd's balance sheet to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$34.10 Million

USD

Capital Expenditures

$277.00K

USD

Data as of

Jun 2023

Most recent filing

Annual Capital Reinvestment Ratio for Bicycle Therapeutics Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Bicycle Therapeutics Ltd from None to None. For live market cap and broader valuation context, see Bicycle Therapeutics Ltd market cap and net worth.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow